CD8A and melanoma: We found that training CellSighter on the melanoma lymph node data and evaluating on the gastrointestinal data achieves high results for major cell types that shared all of their defining proteins, including CD4 T cells (88%), Tregs (83%), CD8 T cells (93%) and Endothelial cells (82%).